The Vizion Expert Series spotlights the leading voices driving innovation in healthcare, life sciences, and medical technology. In this episode, we explore how point-of-care AI is moving beyond the “black box” to become a vital clinical co-pilot in the complex field of oncology.
In this episode, hosts Rebecca Maniago, PharmD, BCOP, Senior Director, Oncology Care Pathway at Viz.ai, and Tim Showalter, MD, MPH, Chief Clinical Officer at Viz.ai, are joined by Adam P. Dicker, MD, PhD, FASTRO, FASCO, EVP & Chair, Radiation Oncology at Thomas Jefferson University, and Paul M. Yonover, MD, FACS, Chief Data Officer at Uropartners, Specialty Alliance.
Together, they discuss the “data explosion” in prostate cancer care and how AI-powered tools can surface the “ground truth” buried within fragmented medical records to deliver truly personalized care and reduce clinical variability.
Topics discussed
- The “Data Explosion” in Oncology: Why the volume of therapeutic options and evolving NCCN guidelines has created a significant “cognitive tax” on clinicians.
- Overcoming Flawed Data: How AI-powered OCR and NLP identify and correct “entrenched” errors in medical charts that lead to clinical variability.
- Visualizing the Patient Journey: The transition from tabular EMR data to longitudinal care journeys to ensure guideline-concordant care.
- Democratizing Expertise: How AI acts as a leveling force, bringing academic-level precision to community health settings.
- The 5-Year Outlook: Predictions on the evolution of AI-driven personalized medicine, including organ aging predictions and automated clinical workflows.